Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors

Background: Cancer is a leading cause of death worldwide. Extensive research over decades has led to the development of therapies that inhibit oncogenic signaling pathways. The mammalian target of rapamycin (mTOR) signaling pathway plays an important role in the development of many cancers. Several...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Theranostics
Autores principales: Xia, Yiqun, Chen, Jundixia, Yu, Yun, Wu, Fengjiao, Shen, Xin, Qiu, Chenyu, Zhang, Tingting, Hong, Lin, Zheng, Peisen, Shao, Rongrong, Xu, Chenxin, Wu, Fang, Chen, Wei, Xie, Congying, Cui, Ri, Zou, Peng
Formato: Artigo
Lenguaje:Inglês
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7977446/
https://ncbi.nlm.nih.gov/pubmed/33754064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.52077
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares